Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02836899 · ClinicalTrials.gov registry record · Phase 3
Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.
A Phase 3 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
NCT02836899: Completed Phase 3 study, sponsored by Massachusetts General Hospital.
NCT02836899 is a Phase 3 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02836899, a Phase 3 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether nitric oxide is effective in the treatment of acute kidney injury in cardiac surgical patients with sign and laboratory data suggesting endothelial dysfunction undergoing prolonged cardiopulmonary bypass.
Interventions
- OTHER Placebo
- DRUG Nitric Oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2017-02-08 |
| Est. Completion | 2025-08-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02836899
The ClinicalTrials.gov registry entry for NCT02836899 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02836899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02836899 about?
NCT02836899 is a clinical study titled "Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.". The purpose of this study is to determine whether nitric oxide is effective in the treatment of acute kidney injury in cardiac surgical patients with sign and laboratory data suggesting endothelial dysfunction undergoing prolonged cardiopulmonary bypass.
What is the current status of trial NCT02836899?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2017-02-08. Estimated completion is 2025-08-15.
What interventions are being tested in trial NCT02836899?
The interventions under investigation include: Placebo (OTHER), Nitric Oxide (DRUG).
Who is sponsoring clinical trial NCT02836899?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.